Evidence map›Paper›PMID 24698946›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2014

Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.

Salka Keller, John T Wilson, Gabriela I Patilea, Hanna B Kern, Anthony J Convertine, Patrick S Stayton

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Magnetically Actuated Biodegradable Nanorobots for Active Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Review
  9. Nanotechnology-Driven Delivery Systems in Inoculation Therapies.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Effect of physicochemical properties onActa pharmaceutica Sinica. B · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Salka KellerDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: salka@uw.edu.
John T WilsonDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: wilsonjt@uw.edu.
Gabriela I PatileaDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: patilg@uw.edu.
Hanna B KernDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: kernh@uw.edu.
Anthony J ConvertineDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: aconv@uw.edu.
Patrick S StaytonDepartment of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-1721, USA. Electronic address: stayton@uw.edu.
University of Washington · US

Funding

University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Biofunctional Polymers for Intracellular Drug DeliveryR01EB002991 · NIBIB · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 2003 to 2011
$3.9M
Intracellular delivery of proapoptotic peptide drugs for the treatment of cancerR21EB014572 · NIBIB · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 2012 to 2013
$450k
NIBIB NIH HHS R01 EB002991NIBIB NIH HHS R01EB002991NIBIB NIH HHS R21 EB014572NIBIB NIH HHS R21EB014572NIGMS NIH HHS GM007266NIGMS NIH HHS T32 GM007266
6 · The paper itself

Abstract

Synthetic subunit vaccines need to induce CD8(+) cytotoxic T cell (CTL) responses for effective vaccination against intracellular pathogens. Most subunit vaccines primarily generate humoral immune responses, with a weaker than desired CD8(+) cytotoxic T cell response. Here, a neutral, pH-responsive polymer micelle carrier that alters intracellular antigen trafficking was shown to enhance CD8(+) T cell responses with a correlated increase in cytosolic delivery and a decrease in exocytosis. Polymer diblock carriers consisted of a N-(2-hydroxypropyl) methacrylamide corona block with pendent pyridyl disulfide groups for reversible conjugation of thiolated ovalbumin, and a tercopolymer ampholytic core-forming block composed of propylacrylic acid (PAA), dimethylaminoethyl methacrylate (DMAEMA), and butyl methacrylate (BMA). The diblock copolymers self-assembled into 25-30nm diameter micellar nanoparticles. Conjugation of ovalbumin to the micelles significantly enhanced antigen cross-presentation in vitro relative to free ovalbumin, an unconjugated physical mixture of ovalbumin and polymer, and a non-pH-responsive micelle-ovalbumin control. Mechanistic studies in a murine dendritic cell line (DC 2.4) demonstrated micelle-mediated enhancements in intracellular antigen retention and cytosolic antigen accumulation. Approximately 90% of initially internalized ovalbumin-conjugated micelles were retained in cells after 1.5h, compared to only ~40% for controls. Furthermore, cells dosed with conjugates displayed 67-fold higher cytosolic antigen levels relative to soluble ovalbumin 4h post uptake. Subcutaneous immunization of mice with ovalbumin-polymer conjugates significantly enhanced antigen-specific CD8(+) T cell responses (0.4% IFN-γ(+) of CD8(+)) compared to immunization with soluble protein, ovalbumin and polymer mixture, and the control micelle without endosome-releasing activity. Additionally, pH-responsive carrier facilitated antigen delivery to antigen presenting cells in the draining lymph nodes. As early as 90min post injection, ova-micelle conjugates were associated with 28% and 55% of dendritic cells and macrophages, respectively. After 24h, conjugates preferentially associated with dendritic cells, affording 30-, 3-, and 3-fold enhancements in uptake relative to free protein, physical mixture, and the non-pH-responsive conjugate controls, respectively. These results demonstrate the potential of pH-responsive polymeric micelles for use in vaccine applications that rely on CD8(+) T cell activation.

Indexed as

AntigensDrug CarriersAnimalsCell LineChemistry, PharmaceuticalDelayed-Action PreparationsDendritic CellsEndosomesFemaleHydrogen-Ion ConcentrationImmunizationLymph NodesLymphocyte ActivationMacrophagesMice, Inbred C57BLMicellesAntigensDelayed-Action PreparationsDrug CarriersMicellesOvalbuminPolymersVaccines, SubunitCD8(+) T cell responseNanoparticlespH-responsivePolymer micellesSubunit vaccine

Identifiers

PMID24698946
PMCPMC4156909
OpenAlexW2087138396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.